Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Desitin Arzneimittel GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10930
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Desitin Arzneimittel GmbH (Desitin) formerly Desitin Compagnie mbH, is a specialty pharmaceutical company which develops and produces products for the treatment of central nervous system (CNS) related neurological and psychiatric diseases. Its product portfolio includes antiepileptic drugs and antiparkinson medication. It offers medicines for illnesses such as Parkinson’s disease, epilepsy, dystonia, actinic keratosis, and post-stroke spasticity. Desitin also provides active pharmaceutical ingredients (APIs), besides manufacturing, clinical development, regulatory support, market access and health care services. It markets and distributes its products through a network of partner companies across Europe. The company has operations with offices in Denmark, Sweden, Norway, Czech Republic, Slovakia, Romania, Switzerland and the UK. Desitin is headquartered in Hamburg, Germany.

Desitin Arzneimittel GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Desitin Arzneimittel Enters Into Co-Promotion Agreement With GlaxoSmithKline For Elontril 10
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 11
Licensing Agreements 12
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 13
Desitin Arzneimittel GmbH – Key Competitors 14
Desitin Arzneimittel GmbH – Key Employees 15
Desitin Arzneimittel GmbH – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Desitin Arzneimittel GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Desitin Arzneimittel Enters Into Co-Promotion Agreement With GlaxoSmithKline For Elontril 10
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 11
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 13
Desitin Arzneimittel GmbH, Key Competitors 14
Desitin Arzneimittel GmbH, Key Employees 15
Desitin Arzneimittel GmbH, Subsidiaries 16

List of Figures
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asian American Medical Group Ltd (AJJ):企業の財務・戦略的SWOT分析
    Asian American Medical Group Ltd (AJJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Almirall SA (ALM):企業の財務・戦略的SWOT分析
    Almirall SA (ALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Midatech Pharma Plc (MTPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Matrix Composites & Engineering Ltd (MCE):企業の財務・戦略的SWOT分析
    Summary Matrix Composites & Engineering Ltd (Matrix) is a manufacturer and supplier of engineered products and services. The company manufactures and distributes engineered products for developing and utilizing advanced composite and polymer materials technologies. Its products include well construc …
  • Hyundai Engineering & Construction Co Ltd (000720):企業の財務・戦略的SWOT分析
    Hyundai Engineering & Construction Co Ltd (000720) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Ramco-Gershenson Properties Trust:企業のM&A・事業提携・投資動向
    Ramco-Gershenson Properties Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ramco-Gershenson Properties Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Assertio Therapeutics Inc (ASRT):企業の財務・戦略的SWOT分析
    Assertio Therapeutics Inc (ASRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Territorial Generation Company No. 11:企業の戦略的SWOT分析
    Territorial Generation Company No. 11 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Agios Pharmaceuticals Inc (AGIO):医療機器:M&Aディール及び事業提携情報
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Ford Motor Company:企業の戦略・SWOT・財務分析
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NCsoft Corporation (036570):企業の財務・戦略的SWOT分析
    NCsoft Corporation (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Zenkyoren:企業の戦略・SWOT・財務情報
    Zenkyoren - Strategy, SWOT and Corporate Finance Report Summary Zenkyoren - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Delphi Energy Corp (DEE):企業の財務・戦略的SWOT分析
    Delphi Energy Corp (DEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • San Raffaele Hospital-製薬・医療分野:企業M&A・提携分析
    Summary San Raffaele hospital (San Raffaele), a subsidiary of Vita-Salute San Raffaele University is a clinical scientific university institution that offers education and healthcare services. The institute provides services through the segments clinic, scientific research, patient services, and hos …
  • The New Zealand Refining Co Ltd (NZR):石油・ガス:M&Aディール及び事業提携情報
    Summary The New Zealand Refining Co Ltd. (Refining NZ) is an oil refining company that refines and distributes oil products. It operates an oil refinery at Marsden Point in Whangarei, New Zealand. The company processes crude oil types imported from offshore markets and produces refined petroleum pro …
  • Shanghai Zhenhua Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Shanghai Zhenhua Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shanghai Zhenhua Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Alon USA Energy Inc (ALJ):企業の財務・戦略的SWOT分析
    Alon USA Energy Inc (ALJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Indeck Energy Services Inc:企業の戦略的SWOT分析
    Indeck Energy Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Protalex Inc (PRTX):企業の財務・戦略的SWOT分析
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • Bulgarian Energy Holding EAD:企業の戦略的SWOT分析
    Bulgarian Energy Holding EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆